ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,464.62
      -0.16%
      US Tech 100
      19,220.00
      -0.20%
      Dow Jones
      39,150.33
      0.04%
      Brent Oil
      84.39
      0.00%
      Bitcoin
      64,045.01
      -0.31%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Silence Therapeutics PLC (SLN)

      7. Silence Therapeutics PLC (SLN) Financials

      Silence Therapeutics PLC

      Silence Therapeutics PLC (SLN)

      NASDAQ
      19.65
      0.70
      (3.69%)
      Closed June 23 4:00PM
      Delayed by 15 minutes
      19.65
      0.00
      (0.00%)
      After Hours: 5:30PM
      Delayed by 15 minutes

      Silence Therapeutics PLC Financial Summary

      The current SLN market cap is 722.09M. The company's latest EPS is GBP -1.1774 and P/E is -5.52.

      Income Statement

      Annual Quarterly
      Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023
      GBP (£)GBP (£)GBP (£)GBP (£)GBP (£)
      Total Revenue 3.64M3.37M4.77M11.37M9.1M
      Operating Income -14.21M-13.62M-10.96M-12.07M-11.15M
      Net Income -11.94M-7.1M-13.76M-10.2M-10.4M
      Year End December 30 2023 20192020202120222023
      GBP (£)GBP (£)GBP (£)GBP (£)GBP (£)
      Total Revenue 244k5.48M12.42M17.5M25.38M
      Operating Income -22.73M-32.48M-45.81M-48.59M-49.6M
      Net Income -19.58M-32.55M-39.41M-40.49M-43.27M

      Balance Sheet

      Annual Quarterly
      Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023
      GBP (£)GBP (£)GBP (£)GBP (£)GBP (£)
      Total Assets 83.4M124.04M107.5M94.34M92.71M
      Total Liabilities 88.14M89.91M85.43M77.75M80.46M
      Total Equity -4.74M34.13M22.07M16.59M12.26M
      Year End December 30 2023 20192020202120222023
      GBP (£)GBP (£)GBP (£)GBP (£)GBP (£)
      Total Assets 46.08M85.97M96.19M107.5M93.82M
      Total Liabilities 25.17M76.91M87.67M85.43M76.77M
      Total Equity 20.91M9.06M8.53M22.07M17.05M

      Cash Flow

      Annual Quarterly
      Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023
      GBP (£)GBP (£)GBP (£)GBP (£)GBP (£)
      Operating -22.64M N/A -45.46M-7.66M-22.61M
      Investing -86k N/A -16.54M128k-4.58M
      Financing -58k N/A 43.05M19k3.2M
      Year End December 30 2023 20192020202120222023
      GBP (£)GBP (£)GBP (£)GBP (£)GBP (£)
      Operating 1.73M-10.78M6.81M-45.46M-39.35M
      Investing -15.02M9.62M8.68M-16.54M16.43M
      Financing 5.27M15.43M30.71M43.05M25.16M

      Stats and Ratios

      Market Cap 722.09M
      Price to Earnings Ratio -5.52
      Price to Sales Ratio 9.41
      Price to Cash Ratio 4.42
      Price to Book Ratio 14.01
      Dividend Yield -

      Share Statistics

      Shares Outstanding 36.75M
      Average Volume (1 week) 0
      Average Volume (1 Month) 0
      52 Week Change -
      52 Week High -
      52 Week Low -
      Spread (Intraday) 4.72 (19.67%)

      Company Info

      Company Name Silence Therapeutics PLC
      Address 27 eastcastle street
      london W1W 8DH
      Website https://www.silence-therapeutics.com
      Industry pharmaceutical preparations (2834)